Induction of viral, 7-methyl-guanosine cap-independent translation and oncolysis by mitogen-activated protein kinase-interacting kinase-mediated effects on the serine/arginine-rich protein kinase

Journal of Virology

Volumn 88, Issue 22, 2014, Pages 13135-13148

  Brown, Michael C ^a   Bryant, Jeffrey D ^a   Dobrikova, Elena Y ^a   Shveygert, Mayya ^a,b   Bradrick, Shelton S ^a   Chandramohan, Vidyalakshmi ^a   Bigner, Darell D ^a   Gromeier, Matthias ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

7 METHYLGUANOSINE; EUKARYOTIC INITIATION FACTOR 4G BINDING PARTNER PROTEIN; INITIATION FACTOR 4E; INITIATION FACTOR 4G; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; SERINE ARGININE RICH PROTEIN; UNCLASSIFIED DRUG; MKNK1 PROTEIN, HUMAN; MKNK2 PROTEIN, HUMAN; PROTEIN SERINE THREONINE KINASE; SIGNAL PEPTIDE; SRPK1 PROTEIN, HUMAN; VIRAL PROTEIN;

ARTICLE; CATALYSIS; CELL MEDIATED CYTOTOXICITY; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; INTERNAL RIBOSOME ENTRY SITE; NONHUMAN; NUCLEAR EXPORT SIGNAL; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN STABILITY; SIGNAL TRANSDUCTION; SUICIDE SUBSTRATE; VIRUS TRANSCRIPTION; BIOSYNTHESIS; CELL LINE; ENTEROVIRUS; GENE EXPRESSION REGULATION; GENETICS; HOST PATHOGEN INTERACTION; HUMAN; METABOLISM; PROTEIN SYNTHESIS;

CELL LINE; ENTEROVIRUS; GENE EXPRESSION REGULATION, VIRAL; HOST-PATHOGEN INTERACTIONS; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MAP KINASE SIGNALING SYSTEM; PROTEIN BIOSYNTHESIS; PROTEIN-SERINE-THREONINE KINASES; VIRAL PROTEINS;

EID: 84908388234     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.01883-14     Document Type: Article

References (58)

1. Kozak M. 1991. An analysis of vertebrate mRNA sequences: intimations of translational control. J. Cell Biol. 115:887-903. http://dx.doi.org/10.1083/jcb.115.4.887.
2. Marintchev A, Edmonds KA, Marintcheva B, Hendrickson E, Oberer M, Suzuki C, Herdy B, Sonenberg N, Wagner G. 2009. Topology and regulation of the human eIF4A/4G/4H helicase complex in translation initiation. Cell 136:447-460. http://dx.doi.org/10.1016/j.cell.2009.01.014.
3. Sweeney TR, Abaeva IS, Pestova TV, Hellen CU. 2014. The mechanism of translation initiation on type 1 picornavirus IRESs. EMBO J. 33:76-92. http://dx.doi.org/10.1002/embj.201386124.
4. Pelletier J, Sonenberg N. 1988. Internal initiation of translation of eukaryotic mRNA directed by a sequence derived from poliovirus RNA. Nature 334:320-325. http://dx.doi.org/10.1038/334320a0.
5. Jang SK, Krausslich HG, Nicklin MJ, Duke GM, Palmenberg AC, Wimmer E. 1988. A segment of the 5' nontranslated region of encephalomyocarditis virus RNA directs internal entry of ribosomes during in vitro translation. J. Virol. 62:2636-2643.
6. Yu Y, Abaeva IS, Marintchev A, Pestova TV, Hellen CU. 2011. Common conformational changes induced in type 2 picornavirus IRESs by cognate trans-acting factors. Nucleic Acid Res. 39:4851-4865. http://dx.doi.org/10.1093/nar/gkr045.
7. Hundsdoerfer P, Thoma C, Hentze MW. 2005. Eukaryotic translation initiation factor 4GI and p97 promote cellular internal ribosome entry sequence-driven translation. Proc. Natl. Acad. Sci. U. S. A. 102:13421-13426. http://dx.doi.org/10.1073/pnas.0506536102.
8. Kaiser C, Dobrikova EY, Bradrick SS, Shveygert M, Herbert JT, Gromeier M. 2008. Activation of cap-independent translation by variant eukaryotic initiation factor 4G in vivo. RNA 14:2170-2182. http://dx.doi.org/10.1261/rna.1171808.
9. Wimmer E, Hellen CU, Cao X. 1993. Genetics of poliovirus. Annu. Rev. Genet. 27:353-436. http://dx.doi.org/10.1146/annurev.ge.27.120193.002033.
10. de Breyne S, Yu Y, Unbehaun A, Pestova TV, Hellen CU. 2009. Direct functional interaction of initiation factor eIF4G with type 1 internal ribosomal entry sites. Proc. Natl. Acad. Sci. U. S. A. 106:9197-9202. http://dx.doi.org/10.1073/pnas.0900153106.
11. Ochs K, Zeller A, Saleh L, Bassili G, Song Y, Sonntag A, Niepmann M. 2003. Impaired binding of standard initiation factors mediates poliovirus translation attenuation. J. Virol. 77:115-122. http://dx.doi.org/10.1128/JVI.77.1.115-122.2003.
12. Merrill MK, Dobrikova EY, Gromeier M. 2006. Cell-type-specific repression of internal ribosome entry site activity by double-stranded RNAbinding protein 76. J. Virol. 80:3147-3156. http://dx.doi.org/10.1128/JVI.80.7.3147-3156.2006.
13. Merrill MK, Gromeier M. 2006. The double-stranded RNA binding protein 76:NF45 heterodimer inhibits translation initiation at the rhinovirus type 2 internal ribosome entry site. J. Virol. 80:6936-6942. http://dx.doi.org/10.1128/JVI.00243-06.
14. Gromeier M, Bossert B, Arita M, Nomoto A, Wimmer E. 1999. Dual stem loops within the poliovirus internal ribosomal entry site control neurovirulence. J. Virol. 73:958-964.
15. Campbell SA, Lin J, Dobrikova EY, Gromeier M. 2005. Genetic determinants of cell type-specific poliovirus propagation in HEK 293 cells. J. Virol. 79:6281-6290. http://dx.doi.org/10.1128/JVI.79.10.6281-6290.2005.
16. Dobrikova EY, Goetz C, Walters RW, Lawson SK, Peggins JO, Muszynski K, Ruppel S, Poole K, Giardina SL, Vela EM, Estep JE, Gromeier M. 2012. Attenuation of neurovirulence, biodistribution, and shedding of a poliovirus: rhinovirus chimera after intrathalamic inoculation in Macaca fascicularis. J. Virol. 86:2750-2759. http://dx.doi.org/10.1128/JVI.06427-11.
17. Gromeier M, Lachmann S, Rosenfeld MR, Gutin PH, Wimmer E. 2000. Intergeneric poliovirus recombinants for the treatment of malignant glioma. Proc. Natl. Acad. Sci. U. S. A. 97:6803-6808. http://dx.doi.org/10.1073/pnas.97.12.6803.
18. Goetz C, Everson RG, Zhang LC, Gromeier M. 2010. MAPK signalintegrating kinase controls cap-independent translation and cell typespecific cytotoxicity of an oncolytic poliovirus. Mol. Ther. 18:1937-1946. http://dx.doi.org/10.1038/mt.2010.145.
19. Dobrikov M, Dobrikova E, Shveygert M, Gromeier M. 2011. Phosphor-ylation of eukaryotic translation initiation factor 4G1 (eIF4G1) by protein kinase C{alpha} regulates eIF4G1 binding to Mnk1. Mol. Cell. Biol. 31: 2947-2959. http://dx.doi.org/10.1128/MCB.05589-11.
20. Shveygert M, Kaiser C, Bradrick SS, Gromeier M. 2010. Regulation of eukaryotic initiation factor 4E (eIF4E) phosphorylation by mitogenactivated protein kinase occurs through modulation of Mnk1-eIF4G interaction. Mol. Cell. Biol. 30:5160-5167. http://dx.doi.org/10.1128/MCB.00448-10.
21. Waskiewicz AJ, Flynn A, Proud CG, Cooper JA. 1997. Mitogen-activated protein kinases activate the serine/threonine kinasesMnk1and Mnk2.EMBO J. 16:1909-1920. http://dx.doi.org/10.1093/emboj/16.8.1909.
22. Ueda T, Sasaki M, Elia AJ, Chio II, Hamada K, Fukunaga R, Mak TW. 2010. Combined deficiency for MAP kinase-interacting kinase 1 and 2 (Mnk1 and Mnk2) delays tumor development. Proc. Natl. Acad. Sci. U. S. A. 107:13984-13990. http://dx.doi.org/10.1073/pnas.1008136107.
23. Grzmil M, Huber RM, Hess D, Frank S, Hynx D, Moncayo G, Klein D, Merlo A, Hemmings BA. 2014. MNK1 pathway activity maintains protein synthesis in rapalog-treated gliomas. J. Clin. Invest. 124:742-754. http://dx.doi.org/10.1172/JCI70198.
24. Blaustein M, Pelisch F, Tanos T, Munoz MJ, Wengier D, Quadrana L, Sanford JR, Muschietti JP, Kornblihtt AR, Caceres JF, Coso OA, Srebrow A. 2005. Concerted regulation of nuclear and cytoplasmic activities of SR proteins by AKT. Nat. Struct. Mol. Biol. 12:1037-1044. http://dx.doi.org/10.1038/nsmb1020.
25. Bedard KM, Daijogo S, Semler BL. 2007. A nucleo-cytoplasmic SR protein functions in viral IRES-mediated translation initiation. EMBO J. 26:459-467. http://dx.doi.org/10.1038/sj.emboj.7601494.
26. Bradrick SS, Walters RW, Gromeier M. 2006. The hepatitis C virus 3'-untranslated region or a poly(A) tract promote efficient translation subsequent to the initiation phase. Nucleic Acid Res. 34:1293-1303. http://dx.doi.org/10.1093/nar/gkl019.
27. Dobrikova E, Florez P, Bradrick S, Gromeier M. 2003. Activity of a type 1 picornavirus internal ribosomal entry site is determined by sequences within the 3' nontranslated region. Proc. Natl. Acad. Sci. U. S. A. 100: 15125-15130. http://dx.doi.org/10.1073/pnas.2436464100.
28. Hall DJ, Bates ME, Guar L, Cronan M, Korpi N, Bertics PJ. 2005. The role of p38 MAPK in rhinovirus-induced monocyte chemoattractant protein-1 production by monocytic-lineage cells. J. Immunol. 174:8056-8063. http://dx.doi.org/10.4049/jimmunol.174.12.8056.
29. Dobrikov MI, Dobrikova EY, Gromeier M. 2013. Dynamic regulation of the translation initiation helicase complex by mitogenic signal transduction to eukaryotic translation initiation factor 4G. Mol. Cell. Biol. 33:937-946. http://dx.doi.org/10.1128/MCB.01441-12.
30. Bradrick SS, Gromeier M. 2009. Identification of gemin5 as a novel 7-methylguanosine cap-binding protein. PLoS One 4:e7030. http://dx.doi.org/10.1371/journal.pone.0007030.
31. Dobrikov MI, Shveygert M, Brown MC, Gromeier M. 2014. Mitotic phosphorylation of eukaryotic initiation factor 4G1 (eIF4G1) at Ser1232 by Cdk1:cyclin B inhibits eIF4A helicase complex binding with RNA. Mol. Cell. Biol. 34:439-451. http://dx.doi.org/10.1128/MCB.01046-13.
32. Bradrick SS, Dobrikova EY, Kaiser C, Shveygert M, Gromeier M. 2007. Poly(A)-binding protein is differentially required for translation mediated by viral internal ribosome entry sites. RNA 13:1582-1593. http://dx.doi.org/10.1261/rna.556107.
33. Bullard DE, Schold SC, Jr, Bigner SH, Bigner DD. 1981. Growth and chemotherapeutic response in athymic mice of tumors arising from human glioma-derived cell lines. J. Neuropathol. Exp. Neurol. 40:410-427. http://dx.doi.org/10.1097/00005072-198107000-00005.
34. Sarkaria JN, Carlson BL, Schroeder MA, Grogan P, Brown PD, Giannini C, Ballman KV, Kitange GJ, Guha A, Pandita A, James CD. 2006. Use of an orthotopic xenograft model for assessing the effect of epidermal growth factor receptor amplification on glioblastoma radiation response. Clin. Cancer Res. 12:2264-2271. http://dx.doi.org/10.1158/1078-0432.CCR-05-2510.
35. Ponten J, Macintyre EH. 1968. Long term culture of normal and neoplastic human glia. Acta Pathol. Microbiol. Scand. 74:465-486.
36. Nagaraj N, Wisniewski JR, Geiger T, Cox J, Kircher M, Kelso J, Paabo S, Mann M. 2011. Deep proteome and transcriptome mapping of a human cancer cell line. Mol. Syst. Biol. 7:548. http://dx.doi.org/10.1038/msb.2011.81.
37. Jauch R, Cho MK, Jakel S, Netter C, Schreiter K, Aicher B, Zweckstetter M, Jackle H, Wahl MC. 2006. Mitogen-activated protein kinases interacting kinases are autoinhibited by a reprogrammed activation segment. EMBO J. 25:4020-4032. http://dx.doi.org/10.1038/sj.emboj.7601285.
38. Scheper GC, Morrice NA, Kleijn M, Proud CG. 2001. The mitogenactivated protein kinase signal-integrating kinase Mnk2 is a eukaryotic initiation factor 4E kinase with high levels of basal activity in mammalian cells. Mol. Cell. Biol. 21:743-754. http://dx.doi.org/10.1128/MCB.21.3.743-754.2001.
39. Brown MC, Dobrikov MI, Gromeier M. 2014. Mitogen-activated protein kinase-interacting kinase regulates mTOR/AKT signaling and controls the serine/arginine-rich protein kinase-responsive type 1 internal ribosome entry site-mediated translation and viral oncolysis. J. Virol. 88:13149-13160. http://dx.doi.org/10.1128/JVI.01884-14.
40. Lewis SM, Veyrier A, Hosszu Ungureanu N, Bonnal S, Vagner S, Holcik M. 2007. Subcellular relocalization of a trans-acting factor regulates XIAP IRES-dependent translation. Mol. Biol. Cell 18:1302-1311. http://dx.doi.org/10.1091/mbc.E06-06-0515.
41. Buxade M, Parra JL, Rousseau S, Shpiro N, Marquez R, Morrice N, Bain J, Espel E, Proud CG. 2005. The Mnks are novel components in the control of TNF alpha biosynthesis and phosphorylate and regulate hnRNP A1. Immunity 23:177-189. http://dx.doi.org/10.1016/j.immuni.2005.06.009.
42. Pyronnet S, Imataka H, Gingras AC, Fukunaga R, Hunter T, Sonenberg N. 1999. Human eukaryotic translation initiation factor 4G (eIF4G) recruits mnk1 to phosphorylate eIF4E. EMBO J. 18:270-279. http://dx.doi.org/10.1093/emboj/18.1.270.
43. Hu SI, Katz M, Chin S, Qi X, Cruz J, Ibebunjo C, Zhao S, Chen A, Glass DJ. 2012. MNK2 inhibits eIF4G activation through a pathway involving serine-arginine-rich protein kinase in skeletal muscle. Sci. Signal 5:ra14. http://dx.doi.org/10.1126/scisignal.2002466.
44. Ngo JC, Chakrabarti S, Ding JH, Velazquez-Dones A, Nolen B, Aubol BE, Adams JA, Fu XD, Ghosh G. 2005. Interplay between SRPK and Clk/Sty kinases in phosphorylation of the splicing factor ASF/SF2 is regulated by a docking motif in ASF/SF2. Mol. Cell 20:77-89. http://dx.doi.org/10.1016/j.molcel.2005.08.025.
45. Zhong XY, Ding JH, Adams JA, Ghosh G, Fu XD. 2009. Regulation of SR protein phosphorylation and alternative splicing by modulating kinetic interactions of SRPK1 with molecular chaperones. Genes Dev. 23: 482-495. http://dx.doi.org/10.1101/gad.1752109.
46. Ding JH, Zhong XY, Hagopian JC, Cruz MM, Ghosh G, Feramisco J, Adams JA, Fu XD. 2006. Regulated cellular partitioning of SR proteinspecific kinases in mammalian cells. Mol. Biol. Cell 17:876-885. http://dx.doi.org/10.1091/mbc.E05-10-0963.
47. Zhou Z, Qiu J, Liu W, Zhou Y, Plocinik RM, Li H, Hu Q, Ghosh G, Adams JA, Rosenfeld MG, Fu XD. 2012. The Akt-SRPK-SR axis constitutes a major pathway in transducing EGF signaling to regulate alternative splicing in the nucleus. Mol. Cell 47:422-433. http://dx.doi.org/10.1016/j.molcel.2012.05.014.
48. Gui JF, Lane WS, Fu XD. 1994. A serine kinase regulates intracellular localization of splicing factors in the cell cycle. Nature 369:678-682. http://dx.doi.org/10.1038/369678a0.
49. Colwill K, Pawson T, Andrews B, Prasad J, Manley JL, Bell JC, Duncan PI. 1996. The Clk/Sty protein kinase phosphorylates SR splicing factors and regulates their intranuclear distribution. EMBO J. 15:265-275.
50. Sanford JR, Gray NK, Beckmann K, Caceres JF. 2004. A novel role for shuttling SR proteins in mRNA translation. Genes Dev. 18:755-768. http://dx.doi.org/10.1101/gad.286404.
51. Lai MC, Lin RI, Tarn WY. 2001. Transportin-SR2 mediates nuclear import of phosphorylated SR proteins. Proc. Natl. Acad. Sci. U. S. A. 98:10154-10159. http://dx.doi.org/10.1073/pnas.181354098.
52. Brown MC, Dobrikova EY, Dobrikov MI, Walton RW, Gemberling SL, Nair SK, Desjardins A, Sampson JH, Friedman HS, Friedman AH, Tyler DS, Bigner DD, Gromeier M. 17 June 2014. Oncolytic polio virotherapy of cancer. Cancer. http://dx.doi.org/10.1002/cncr.28862.
53. Huang Y, Steitz JA. 2005. SRprises along a messenger's journey. Mol. Cell 17:613-615. http://dx.doi.org/10.1016/j.molcel.2005.02.020.
54. Caceres JF, Screaton GR, Krainer AR. 1998. A specific subset of SR proteins shuttles continuously between the nucleus and the cytoplasm. Genes Dev. 12:55-66. http://dx.doi.org/10.1101/gad.12.1.55.
55. Blyn LB, Swiderek KM, Richards O, Stahl DC, Semler BL, Ehrenfeld E. 1996. Poly(rC) binding protein 2 binds to stem-loop IV of the poliovirus RNA5' noncoding region: identification by automated liquid chromatography-tandem mass spectrometry. Proc. Natl. Acad. Sci. U. S. A. 93: 11115-11120. http://dx.doi.org/10.1073/pnas.93.20.11115.
56. Spahn CM, Kieft JS, Grassucci RA, Penczek PA, Zhou K, Doudna JA, Frank J. 2001. Hepatitis C virus IRES RNA-induced changes in the conformation of the 40s ribosomal subunit. Science 291:1959-1962. http://dx.doi.org/10.1126/science.1058409.
57. Wang L, Jeng KS, Lai MM. 2011. Poly(C)-binding protein 2 interacts with sequences required for viral replication in the hepatitis C virus (HCV) 5' untranslated region and directs HCV RNA replication through circularizing the viral genome. J. Virol. 85:7954-7964. http://dx.doi.org/10.1128/JVI.00339-11.
58. Sebolt-Leopold JS, Herrera R. 2004. Targeting the mitogen-activated protein kinase cascade to treat cancer. Nat. Rev. Cancer 4:937-947. http://dx.doi.org/10.1038/nrc1503.